SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-003067
Filing Date
2024-02-02
Accepted
2024-02-02 16:23:00
Documents
22
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K val-20240201.htm   iXBRL 8-K 37067
2 EX-4.1 exhibit41-8xk.htm EX-4.1 112294
3 EX-4.2 exhibit42-8xk.htm EX-4.2 117336
4 EX-4.3 exhibit43-8xk.htm EX-4.3 115458
5 EX-10.1 exhibit101-8xk.htm EX-10.1 289380
6 EX-10.2 exhibit102-8xk.htm EX-10.2 62251
7 EX-10.3 exhibit103-8xk.htm EX-10.3 33029
8 EX-99.1 exhibit991-8xk.htm EX-99.1 12729
12 gribiologo.jpg GRAPHIC 44459
  Complete submission text file 0001628280-24-003067.txt   1133850

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT val-20240201.xsd EX-101.SCH 1913
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT val-20240201_lab.xml EX-101.LAB 26851
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT val-20240201_pre.xml EX-101.PRE 14125
24 EXTRACTED XBRL INSTANCE DOCUMENT val-20240201_htm.xml XML 3091
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 24591812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)